## PG: Procter & Gamble Company (The) - XLP: Consumer Defensive

### Executive Summary

No thesis match: MRS_10 -6.1% below STRENGTH zone (3.0-6.0%); PEG 4.62 fails VALUE criteria (<1.0); RSI 28 oversold (REVERSION excluded per A/B test). Stock is in no-man's land without clear edge. Caution: momentum weakening (-2.3% MRS).

- **Horizon:** N/A - no position
- **Risk Profile:** N/A - avoiding
- **Stop Type:** Fixed 2xATR ($133.00)
- **If Wrong:** N/A - wait for clearer setup
- **Invalidation:** MRS_10 falling below -5% or breaking key support

### News

- **Articles:** 10
- **Sentiment:** Bullish (Bullish: 2, Bearish: 0)

**1. PG Stock Price Near 2â€‘Year Low as P&G Warns on U.S. Sales: Outlook, Forecasts and Dividend Update**
- Source: ts2.tech | 20251207T220850 | Neutral | Relevance: 99%
- Procter & Gamble (NYSE: PG) stock is trading near a two-year low despite strong earnings and a long history of dividend growth, largely due to warnings about weaker U.S. sales, a 7,000-job restructuring, and an upcoming CEO transition. While analysts broadly recommend a "Buy" with an average 12-month target implying 16-22% upside, valuation opinions vary, and technical indicators suggest weak momentum. The company maintains its full-year guidance, anticipating a recovery in U.S. demand later in the fiscal year, and continues to offer a robust dividend yield of approximately 3% for income-focused investors.

**2. Procter & Gamble Company (The) $PG Holdings Raised by Epoch Investment Partners Inc.**
- Source: MarketBeat | 20251206T095346 | Somewhat-Bullish | Relevance: 98%
-  Epoch Investment Partners Inc. increased its stake in Procter & Gamble Company (NYSE:PG) by 10.7% in the second quarter, bringing its total holdings to 161,475 shares valued at over $25.7 million. Other institutional investors have also adjusted their positions in the company, which continues to see analyst ratings ranging from "Buy" to "Hold" with an average price target of $171.53. Procter & Gamble recently announced a quarterly dividend and reported solid earnings, exceeding analyst expectations.

**3. Ossiam Has $58.89 Million Position in Procter & Gamble Company (The) $PG**
- Source: MarketBeat | 20251208T115541 | Neutral | Relevance: 98%
- Ossiam significantly increased its stake in Procter & Gamble (NYSE:PG) by 212.5% in the second quarter, bringing its total holdings to $58.888 million. This makes P&G Ossiam's 28th largest holding. Other institutional investors also adjusted their positions, and insider activity shows recent stock sales by P&G's CEO and CFO.

**4. Federated Hermes Inc. Sells 11,292 Shares of Procter & Gamble Company (The) $PG**
- Source: MarketBeat | 20251208T094717 | Somewhat-Bullish | Relevance: 98%
-  Federated Hermes Inc. reduced its stake in Procter & Gamble (NYSE:PG) by 2.4% during Q2, selling 11,292 shares and now holding 450,347 shares valued at approximately $71.75 million. Meanwhile, insider sales were noted from COO Shailesh Jejurikar and CFO Andre Schulten. The stock is currently trading near its 52-week low but has an average analyst target price of $171.53, indicating a "Moderate Buy" consensus.

**5. California Public Employees Retirement System Reduces Stock Holdings in Procter & Gamble Company (The) $PG**
- Source: MarketBeat | 20251207T090842 | Neutral | Relevance: 98%
-  The California Public Employees Retirement System (CalPERS) reduced its stake in Procter & Gamble (NYSE:PG) by 15.7% in Q2, selling approximately 1.28 million shares and now holding 6.87 million shares valued at about $1.094 billion. This reduction makes Procter & Gamble the 18th largest position in CalPERS' holdings, representing 0.7% of its total portfolio. Insider selling also occurred, with CEO Gary A. Coombe and COO Shailesh Jejurikar selling shares in early October, while several other institutional investors either increased or initiated positions in the company.

### Insider Activity (90 days)

| Metric | Value |
|--------|-------|
| Direction | **NET_SELLING** |
| Buys | 46 ($0.05M) |
| Sells | 17 ($4.90M) |

### Institutional Ownership

| Metric | Value |
|--------|-------|
| Total Ownership | 32.6% |
| Smart Money | **BULLISH** |
| Net Flow | 0.0% |
| Buying/Selling | 6 / 3 |

**Top Holders:**
- Vanguard Group Inc: 10.0% (+0.6%)
- Blackrock Inc.: 7.6% (+3.8%)
- State Street Corpora: 4.3% (+0.4%)
- Geode Capital Manage: 2.6% (+2.1%)
- Morgan Stanley: 2.2% (-1.3%)

### Key Risks

1. Momentum deterioration: MRS_10 falling (-2.3% 5d) with bearish MACD, trend may be turning.
2. Insider selling cluster: $4.9M in recent transactions.
3. Valuation stretched: PEG 4.6x requires aggressive growth execution.
4. Long-term trend broken: trading 12.7% below SMA200.

### Catalysts

- AI/machine learning initiatives could drive multiple expansion if executed.
- Broader market risk-on sentiment could lift quality names.

### Fundamentals

PEG ratio 4.62 signals overvaluation risk, limited margin of safety. Forward P/E 18.8x stretched relative to 5% growth. Quality metrics strong (ROE 32%, ROA 11%, margin 20%). Balance sheet: $4.2B free cash flow. Insider selling cluster ($4.9M in 90 days), potential headwind. Institutional flow bullish (6 buying vs 3 selling).

| Metric | Value |
|--------|-------|
| Market Cap | $323.8B |
| Beta | 0.38 |
| 52W Range | $138.19 - $179.99 |
| Short Interest | 0.8% |

| Valuation | Value |
|-----------|-------|
| PEG Ratio | 4.62 |
| Forward P/E | 18.8 |
| Current P/E | 19.8 |
| YoY Growth | 5.4% |
| EPS Direction | STABLE |

### Technicals

MRS_10 deteriorating from -3.8% to -6.1% (-2.3% in 5 days), indicating relative weakness vs NASDAQ. Below STRENGTH zone by 9.1pp (needs >3.0% for momentum thesis). Underperforming sector by 4.1pp, stock-specific weakness. Below SMA200 (0.87x), long-term trend not supportive. MACD histogram bearish (-0.65), momentum weakening. RSI oversold at 28, potential bounce setup.

| Metric | Value | Signal |
|--------|-------|--------|
| MRS_10 | -6.09% (CS: 3) | Weak |
| RSI_14 | 27.8 | Oversold |
| MACD Histogram | -0.65 | Bearish |
| vs SMA20 | 0.942x | Below |
| vs SMA50 | 0.929x | Below |
| vs SMA200 | 0.873x | Below |

### Decision

- **Verdict:** AVOID
- **Thesis:** NEUTRAL

### Trade Setup

- **Entry:** $138.34
- **Stop Loss:** $133.00 (3.9% risk)
- **Target:** $143.68 (R:R method)
- **Risk/Reward:** 1.00:1
- **Target Reasoning:** NEUTRAL thesis targets 1.0x risk/reward based on historical edge

### Position Sizing

- **Shares:** 93
- **Position Value:** $12,865.62
- **Portfolio %:** 12.87%
- **Risk Dollars:** $500.00
- **Risk Per Trade:** 0.50%
- **Modifiers:** L1 100% | L2 50% | Combined 0.50x

### Market Context

| Layer | Signal | Modifier |
|-------|--------|----------|
| L1 Macro | NORMAL (MEDIUM) | 1.00x |
| L2 Sector | AVOID (Zone C) | 0.50x |

### Earnings

**Next:** 2026-01-22 (Est: $1.88)

| Quarter | Est | Actual | Surprise |
|---------|-----|--------|----------|
| 2025Q3 | $1.90 | $1.99 | +4.9% |
| 2025Q2 | $1.42 | $1.48 | +4.1% |
| 2025Q1 | $1.53 | $1.54 | +0.9% |
| 2024Q4 | $1.86 | $1.88 | +1.1% |

---
*RULE-based L3 | 2026-01-06 16:37 | MRS_10*